newsfilter
← Latest News
FDA Approved Drugs·

Approval of Azulfidine En-tabs, Nda #007073 (Labeling)

Approval Date: 10/14/2026; Drug Name: Azulfidine En-tabs, Nda #007073; Active Ingredients: SULFASALAZINE; Company: Pfizer; Submission Status: Approval; Submission Classification: Labeling; Application Number: 007073

Company
PFIZER
Keywords
PFIZER